Panoncial, Janice .
HRN: 28-23-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/08/2025
CEFUROXIME 1.5GM (VIAL)
12/08/2025
12/11/2025
IV
1.5g
Q8h
S/P CS
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes